Vanguard Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$68.7M Sell
1,932,450
-13,981
-0.7% -$551K ﹤0.01% 1734
2026
Q2
$90.3M Buy
1,946,431
+236,169
+14% +$8.5M ﹤0.01% 1603
2026
Q1
$41.9M Buy
+1,710,262
New +$40.5M ﹤0.01% 1948

Other funds holding ASTH

Vanguard Capital Management's ASTH Position: Q3 2026 in Review

Vanguard Capital Management reduced its Astrana Health (ASTH) stake by 0.72% in Q3 2026, selling an estimated $551K and leaving 1,932,450 shares worth $68.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1734.

Vanguard Capital Management first reported a position in ASTH in Q1 2026 and has held it in 3 quarters since. The position peaked at $90.3M in Q2 2026. 218 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Vanguard Capital Management held 1,932,450 shares of Astrana Health worth $68.7M as of Q3 2026.
  • Vanguard Capital Management sold 13,981 Astrana Health shares in Q3 2026, an estimated $551K.
  • Astrana Health made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1734 holding.
  • Vanguard Capital Management first reported a position in Astrana Health in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's Astrana Health position peaked at $90.3M in Q2 2026.
  • 218 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.